| __timestamp | Novo Nordisk A/S | Soleno Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13762000000 | 2242216 |
| Thursday, January 1, 2015 | 13608000000 | 4536244 |
| Friday, January 1, 2016 | 14563000000 | 5184803 |
| Sunday, January 1, 2017 | 14014000000 | 3068742 |
| Monday, January 1, 2018 | 14805000000 | 7178000 |
| Tuesday, January 1, 2019 | 14220000000 | 16267000 |
| Wednesday, January 1, 2020 | 15462000000 | 23191000 |
| Friday, January 1, 2021 | 17772000000 | 21453000 |
| Saturday, January 1, 2022 | 24047000000 | 15265000 |
| Sunday, January 1, 2023 | 32443000000 | 25189000 |
Data in motion
In the world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Novo Nordisk A/S and Soleno Therapeutics, Inc. have taken markedly different paths in their R&D investments. From 2014 to 2023, Novo Nordisk's R&D spending surged by an impressive 136%, reaching a peak in 2023. This Danish giant, known for its diabetes care products, consistently allocated substantial resources to maintain its competitive edge.
In contrast, Soleno Therapeutics, a smaller player focused on rare diseases, saw its R&D expenses grow by over 1,000% during the same period, albeit from a much smaller base. This dramatic increase underscores Soleno's commitment to innovation despite its limited resources. The stark contrast in R&D spending between these two companies highlights the diverse strategies within the pharmaceutical industry, where both giants and niche players strive to make their mark.
Novo Nordisk A/S or Pfizer Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Amgen Inc.
Novo Nordisk A/S vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Research and Development Investment: Novo Nordisk A/S vs Blueprint Medicines Corporation
Analyzing R&D Budgets: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Novo Nordisk A/S or Bausch Health Companies Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Wave Life Sciences Ltd.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Soleno Therapeutics, Inc.
Pharming Group N.V. vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Soleno Therapeutics, Inc. vs Travere Therapeutics, Inc.
Soleno Therapeutics, Inc. vs BioCryst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending